CINECA IRIS Institutional Research Information System

DI RENZO, Maria Flavia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.881
EU - Europa 3.150
AS - Asia 1.703
AF - Africa 39
OC - Oceania 15
SA - Sud America 5
Totale 9.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.764
CN - Cina 904
IT - Italia 482
IE - Irlanda 460
SE - Svezia 437
UA - Ucraina 341
SG - Singapore 333
DE - Germania 331
FR - Francia 295
FI - Finlandia 282
KR - Corea 242
GB - Regno Unito 231
CA - Canada 115
AT - Austria 111
PL - Polonia 99
VN - Vietnam 73
IN - India 51
BE - Belgio 32
SN - Senegal 32
JP - Giappone 26
ID - Indonesia 22
TW - Taiwan 18
AU - Australia 15
NL - Olanda 15
RU - Federazione Russa 11
ES - Italia 7
HK - Hong Kong 7
RO - Romania 7
TR - Turchia 6
UZ - Uzbekistan 5
IR - Iran 4
NG - Nigeria 4
BG - Bulgaria 3
CL - Cile 3
PK - Pakistan 3
CH - Svizzera 2
MU - Mauritius 2
MX - Messico 2
MY - Malesia 2
TH - Thailandia 2
AM - Armenia 1
BD - Bangladesh 1
BR - Brasile 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 9.793
Salva come PNG Salva come JPEG
Città #
Chandler 816
Beijing 630
Dublin 460
Houston 288
Ann Arbor 269
Singapore 232
Fairfield 225
Jacksonville 217
Ashburn 211
Medford 175
Princeton 169
Villeurbanne 168
Dearborn 166
Woodbridge 163
Nyköping 133
Wilmington 126
Vienna 109
Torino 98
Warsaw 92
Milan 89
Seattle 85
Cambridge 72
Toronto 70
Boston 57
Boardman 55
Dong Ket 50
Verona 47
Pisa 46
Fremont 44
Turin 31
Brussels 30
Munich 30
New York 30
Hefei 28
Santa Clara 28
Lachine 26
Nanjing 26
Guangzhou 25
Norwalk 24
Jakarta 22
Kunming 22
Falls Church 21
Redwood City 20
Los Angeles 17
Washington 17
Shanghai 15
Taipei 14
Jinan 13
Mangalore 13
Nanchang 13
Silver Spring 13
San Diego 12
Ottawa 11
Pune 11
Auburn Hills 10
Hangzhou 9
Tappahannock 9
Tokyo 9
Turku 9
Wuhan 9
Düsseldorf 8
Hebei 8
Xian 8
Buffalo 7
Dallas 7
Mountain View 7
Paris 7
Phoenix 7
Rome 7
Tsukishima 7
Zhengzhou 7
Utrecht 6
Chengdu 5
Fuzhou 5
Helsinki 5
Redmond 5
Shenyang 5
Abuja 4
Carrara 4
Florence 4
Manchester 4
Menlo Park 4
Nuremberg 4
Savigliano 4
Shenzhen 4
Udine 4
Amsterdam 3
Beinasco 3
Bengaluru 3
Berlin 3
Changsha 3
Grafing 3
Harbin 3
Hillsborough 3
Hong Kong 3
Lodi 3
Montréal 3
Nürnberg 3
Polska 3
Santiago 3
Totale 6.118
Salva come PNG Salva come JPEG
Nome #
PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy 322
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 232
A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging 193
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas 174
Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 151
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer. 147
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. 144
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. 144
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 142
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. 131
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 130
Biosynthesis of the protein encoded by the c-met proto-oncogene 123
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers 119
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 118
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase. 114
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells 111
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 110
Atlante di Istologia e Anatomia Microscopica 106
[Molecular markers study in pTNM of squamous carcinoma of the head and neck] 105
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein 104
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF 103
Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin 99
Sparsely-connected autoencoder (SCA) for single cell RNAseq data mining 97
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth 95
Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR. 94
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma 94
Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1. 93
IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness. 93
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism 90
Characterization of T lymphocytes mediating in vivo protection against RSV-induced murine sarcomas. 89
The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo 88
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C 87
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism. 87
Immunofluorescence study of fibronectin distribution in the developing chick embryo striated muscles. 83
Monoclonal antibodies to the collagen binding domain of human plasma fibronectin. 83
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression 82
Tyrosine kinase receptor indistinguishable from the c-met protein. 82
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions 82
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C 81
[Tyrosine-phosphorylated proteins in human breast carcinoma] 78
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS 78
Control of invasive growth by the HGF receptor family. 77
Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. 77
Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation 76
Altered regulation of receptor associated-tyrosine kinases in human tumors 76
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. 76
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway 74
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer 74
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. 73
Proteins phosphorylated on tyrosine as markers of human tumor cell lines 73
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 73
The c-met/HGF receptor in human tumours. 72
Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line. 72
Tyrosine kinase and control of cell proliferation 71
Overexpression of the met/HGF receptor in renal cell carcinomas. 69
p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis 69
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications. 69
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 67
Cells lacking fumarase are protected from apoptosis through a HIF independent, AMPK dependent mechanism 67
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer 65
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis 65
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling 65
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin 64
Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts 63
Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid. 63
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. 63
The MET-oncogene transforms human primary cultures of bone-derived cells by targeting osteo-progenitors. 62
Selective expression of the Met/HGF receptor in human central nervous system microglia 61
Detection of phosphotyrosine-containing proteins in the detergent-insoluble fraction of RSV-transformed fibroblasts by azobenzene phosphonate antibodies. 60
Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. 60
Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein. 60
LE PROPRIETÀ ONCOSOPPRESSIVE INTRINSECHE DELL’ONCOGENE MET COME STRUMENTO DI MORTE APOPTOTICA DELLE CELLULE TUMORALI 59
MET overexpression turns human primary osteoblasts into osteosarcomas 59
Characterization of stable spontaneous metastatic variant lines of RSV-transformed mouse fibroblasts. 58
Overexpression of the RON gene in human breast carcinoma 58
MET receptor is overexpressed but not mutated in oral squamous cell carcinomas 58
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. 58
Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion 58
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 58
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs 58
p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line. 58
Patient-derived cancer models 58
Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin 56
[Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors] 55
Role of heterochromatin variation in the instability of a marker chromosome during tumor progression 55
Organization of cytoskeleton and fibronectin matrix in Rous sarcoma virus (RSV)-transformed fibroblast lines with different metastatic potential. 55
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 55
p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis 55
Genetics in renal cancer 55
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel 55
Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity. 53
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. 52
Thermal behavior of high silica mordenite 52
Immunological detection of proteins phosphorylated at tyrosine in cells stimulated by growth factors or transformed by retroviral-oncogene-coded tyrosine kinases 51
Expression of the MET/HGF receptor in human pancreatic cancer 50
Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis 50
Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase. 50
Lipid characteristics of RSV-transformed Balb/c 3T3 cell lines with different spontaneous metastatic potentials 50
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas 50
Protein tyrosine kinases associated with human malignancies 49
Totale 8.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.102
article - articoli 0
book - libri 0
conference - conferenze 5.235
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.196 0 0 0 120 116 273 195 67 144 135 94 52
2020/20211.060 116 47 87 53 84 45 133 53 141 105 53 143
2021/20221.331 34 48 56 78 47 50 105 65 35 92 320 401
2022/20232.144 271 174 89 204 191 525 161 119 218 28 103 61
2023/2024814 123 148 39 47 35 144 28 43 5 33 46 123
2024/2025335 16 178 72 69 0 0 0 0 0 0 0 0
Totale 10.158